<?xml version='1.0' encoding='utf-8'?>
<document id="19499573"><sentence text="Drug-drug interaction between oxycodone and adjuvant analgesics in blood-brain barrier transport and antinociceptive effect."><entity charOffset="30-39" id="DDI-PubMed.19499573.s1.e0" text="oxycodone" /></sentence><sentence text="To examine possible blood-brain barrier (BBB) transport interactions between oxycodone and adjuvant analgesics, we firstly screened various candidates in vitro using [(3)H]pyrilamine, a substrate of the oxycodone transporter, as a probe drug"><entity charOffset="77-86" id="DDI-PubMed.19499573.s2.e0" text="oxycodone" /><entity charOffset="166-182" id="DDI-PubMed.19499573.s2.e1" text="[(3)H]pyrilamine" /><entity charOffset="203-212" id="DDI-PubMed.19499573.s2.e2" text="oxycodone" /><pair ddi="false" e1="DDI-PubMed.19499573.s2.e0" e2="DDI-PubMed.19499573.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s2.e0" e2="DDI-PubMed.19499573.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s2.e0" e2="DDI-PubMed.19499573.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s2.e1" e2="DDI-PubMed.19499573.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s2.e1" e2="DDI-PubMed.19499573.s2.e2" /></sentence><sentence text=" The uptake of [(3)H]pyrilamine by conditionally immortalized rat brain capillary endothelial cells (TR-BBB13) was inhibited by antidepressants (amitriptyline, imipramine, clomipramine, amoxapine, and fluvoxamine), antiarrhythmics (mexiletine, lidocaine, and flecainide), and ketamine"><entity charOffset="15-31" id="DDI-PubMed.19499573.s3.e0" text="[(3)H]pyrilamine" /><entity charOffset="145-158" id="DDI-PubMed.19499573.s3.e1" text="amitriptyline" /><entity charOffset="160-170" id="DDI-PubMed.19499573.s3.e2" text="imipramine" /><entity charOffset="172-184" id="DDI-PubMed.19499573.s3.e3" text="clomipramine" /><entity charOffset="186-195" id="DDI-PubMed.19499573.s3.e4" text="amoxapine" /><entity charOffset="201-212" id="DDI-PubMed.19499573.s3.e5" text="fluvoxamine" /><entity charOffset="232-242" id="DDI-PubMed.19499573.s3.e6" text="mexiletine" /><entity charOffset="244-253" id="DDI-PubMed.19499573.s3.e7" text="lidocaine" /><entity charOffset="259-269" id="DDI-PubMed.19499573.s3.e8" text="flecainide" /><entity charOffset="276-284" id="DDI-PubMed.19499573.s3.e9" text="ketamine" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e0" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e1" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e2" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e3" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e4" e2="DDI-PubMed.19499573.s3.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e4" e2="DDI-PubMed.19499573.s3.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e4" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e4" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e4" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e4" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e5" e2="DDI-PubMed.19499573.s3.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e5" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e5" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e5" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e5" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e6" e2="DDI-PubMed.19499573.s3.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e6" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e6" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e6" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e7" e2="DDI-PubMed.19499573.s3.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e7" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e7" e2="DDI-PubMed.19499573.s3.e9" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e8" e2="DDI-PubMed.19499573.s3.e8" /><pair ddi="false" e1="DDI-PubMed.19499573.s3.e8" e2="DDI-PubMed.19499573.s3.e9" /></sentence><sentence text=" On the other hand, antiepileptics (carbamazepine, phenytoin, and clonazepam) and corticosteroids (dexamethasone and prednisolone) did not inhibit [(3)H]pyrilamine uptake, with the exception of sodium valproate"><entity charOffset="36-49" id="DDI-PubMed.19499573.s4.e0" text="carbamazepine" /><entity charOffset="51-60" id="DDI-PubMed.19499573.s4.e1" text="phenytoin" /><entity charOffset="66-76" id="DDI-PubMed.19499573.s4.e2" text="clonazepam" /><entity charOffset="82-97" id="DDI-PubMed.19499573.s4.e3" text="corticosteroids" /><entity charOffset="99-112" id="DDI-PubMed.19499573.s4.e4" text="dexamethasone" /><entity charOffset="117-129" id="DDI-PubMed.19499573.s4.e5" text="prednisolone" /><entity charOffset="147-163" id="DDI-PubMed.19499573.s4.e6" text="[(3)H]pyrilamine" /><entity charOffset="194-210" id="DDI-PubMed.19499573.s4.e7" text="sodium valproate" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e0" e2="DDI-PubMed.19499573.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e1" e2="DDI-PubMed.19499573.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e2" e2="DDI-PubMed.19499573.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e2" e2="DDI-PubMed.19499573.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e2" e2="DDI-PubMed.19499573.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e2" e2="DDI-PubMed.19499573.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e2" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e2" e2="DDI-PubMed.19499573.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e3" e2="DDI-PubMed.19499573.s4.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e3" e2="DDI-PubMed.19499573.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e3" e2="DDI-PubMed.19499573.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e3" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e3" e2="DDI-PubMed.19499573.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e4" e2="DDI-PubMed.19499573.s4.e4" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e4" e2="DDI-PubMed.19499573.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e4" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e4" e2="DDI-PubMed.19499573.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e5" e2="DDI-PubMed.19499573.s4.e5" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e5" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e5" e2="DDI-PubMed.19499573.s4.e7" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e6" e2="DDI-PubMed.19499573.s4.e6" /><pair ddi="false" e1="DDI-PubMed.19499573.s4.e6" e2="DDI-PubMed.19499573.s4.e7" /></sentence><sentence text=" The uptake of oxycodone was significantly inhibited in a concentration-dependent manner by amitriptyline, fluvoxamine and mexiletine with K(i) values of 13, 65, and 44 microM, respectively"><entity charOffset="15-24" id="DDI-PubMed.19499573.s5.e0" text="oxycodone" /><entity charOffset="92-105" id="DDI-PubMed.19499573.s5.e1" text="amitriptyline" /><entity charOffset="107-118" id="DDI-PubMed.19499573.s5.e2" text="fluvoxamine" /><entity charOffset="123-133" id="DDI-PubMed.19499573.s5.e3" text="mexiletine" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e0" e2="DDI-PubMed.19499573.s5.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e0" e2="DDI-PubMed.19499573.s5.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e0" e2="DDI-PubMed.19499573.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e0" e2="DDI-PubMed.19499573.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e1" e2="DDI-PubMed.19499573.s5.e1" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e1" e2="DDI-PubMed.19499573.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e1" e2="DDI-PubMed.19499573.s5.e3" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e2" e2="DDI-PubMed.19499573.s5.e2" /><pair ddi="false" e1="DDI-PubMed.19499573.s5.e2" e2="DDI-PubMed.19499573.s5.e3" /></sentence><sentence text=" These K(i) values are 5-300 times greater than the human therapeutic plasma concentrations" /><sentence text=" Finally, we evaluated in vivo interaction between oxycodone and amitriptyline in mice"><entity charOffset="51-60" id="DDI-PubMed.19499573.s7.e0" text="oxycodone" /><entity charOffset="65-78" id="DDI-PubMed.19499573.s7.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.19499573.s7.e0" e2="DDI-PubMed.19499573.s7.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s7.e0" e2="DDI-PubMed.19499573.s7.e1" /></sentence><sentence text=" Antinociceptive effects of oxycodone were increased by coadministration of amitriptyline"><entity charOffset="28-37" id="DDI-PubMed.19499573.s8.e0" text="oxycodone" /><entity charOffset="76-89" id="DDI-PubMed.19499573.s8.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.19499573.s8.e0" e2="DDI-PubMed.19499573.s8.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s8.e0" e2="DDI-PubMed.19499573.s8.e1" /></sentence><sentence text=" The oxycodone concentrations in plasma and brain were not changed by coadministration of amitriptyline"><entity charOffset="5-14" id="DDI-PubMed.19499573.s9.e0" text="oxycodone" /><entity charOffset="90-103" id="DDI-PubMed.19499573.s9.e1" text="amitriptyline" /><pair ddi="false" e1="DDI-PubMed.19499573.s9.e0" e2="DDI-PubMed.19499573.s9.e0" /><pair ddi="false" e1="DDI-PubMed.19499573.s9.e0" e2="DDI-PubMed.19499573.s9.e1" /></sentence><sentence text=" Overall, the results suggest that several adjuvant analgesics may interact with the BBB transport of oxycodone at relatively high concentrations"><entity charOffset="102-111" id="DDI-PubMed.19499573.s10.e0" text="oxycodone" /></sentence><sentence text=" However, it is unlikely that there would be any significant interaction at therapeutically or pharmacologically relevant concentrations" /><sentence text="" /></document>